Literature Collection

Magnifying Glass
Collection Insights

12K+

References

11K+

Articles

1600+

Grey Literature

4800+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
12780 Results
1022
Adolescent nonmedical users of prescription opioids: Brief screening and substance use disorders
Type: Journal Article
Authors: Sean Esteban McCabe, Brady T. West, Christian J. Teter, James A. Cranford, Paula L. Ross-Durow, Carol J. Boyd
Year: 2012
Topic(s):
Opioids & Substance Use See topic collection
1023
Adolescent preferences for a pediatric primary care-based sexually transmitted infection and HIV prevention intervention
Type: Journal Article
Authors: Sarah M. Wood, José Bauermeister, Alexander G. Fiks, Alexis W. Phillips, Haley M. Richardson, Stephanie M. Garcia, Pegah Maleki, Rinad S. Beidas, Jami F. Young, Robert Gross, Nadia Dowshen
Year: 2024
Topic(s):
Healthcare Disparities See topic collection
1024
Adolescent SBIRT implementation: Generalist vs. Specialist models of service delivery in primary care
Type: Journal Article
Authors: S. G. Mitchell, J. Gryczynski, R. P. Schwartz, A. S. Kirk, K. Dusek, M. Oros, C. Hosler, K. E. O'Grady, B. S. Brown
Year: 2020
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
1025
Adolescent Stress Management in a Primary Care Clinic
Type: Journal Article
Authors: E. B. Mason, K. Burkhart, R. Lazebnik
Year: 2019
Publication Place: United States
Topic(s):
General Literature See topic collection
1026
Adolescent substance abuse and treatment acceptability
Type: Journal Article
Authors: Janet F. Williams
Year: 2011
Publication Place: Netherlands: Elsevier Science
Topic(s):
Medical Home See topic collection
1027
Adolescent substance use screening in primary care: Validity of computer self-administered versus clinician-administered screening
Type: Journal Article
Authors: Sion Kim Harris, John Rogers Knight Jr., Shari Van Hook, Lon Sherritt, Traci L. Brooks, John W. Kulig, Christina A. Nordt, Richard Saitz
Year: 2016
Topic(s):
Opioids & Substance Use See topic collection
,
Measures See topic collection
1028
Adolescent Substance Use Screening Tools
Type: Web Resource
Authors: National Institute on Drug Abuse
Year: 2016
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
,
Measures See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

1029
Adolescent substance use: the role of the medical home
Type: Journal Article
Authors: S. Levy, J. F. Williams
Year: 2014
Publication Place: United States
Abstract: Given the continued high rates of substance use by adolescents and young adults, it should be among the topics addressed at every health care visit in the medical home. Primary care physicians should counsel and refer parents for substance use assessment, counseling, and cessation management when pediatric or adolescent patients are environmentally exposed to substances and substance use. The role of the medical home includes providing parents, children, and adolescents with anticipatory guidance, drug use screening, health advice, brief intervention, and referral for further assessment and treatment when an SUD is suspected. Clinical and technical reports, policy statements, and educational materials provided by national institutes and health professional societies assist those caring for children and adolescents by assuring best practices in detailed guidance and developmentally appropriate strategies related to alcohol, tobacco, and other substance use across the pediatric age range.
Topic(s):
Healthcare Disparities See topic collection
,
Medical Home See topic collection
1031
Adolescents and Opioid Substance Use Case Studies
Type: Journal Article
Authors: Albert Anthony Rundio Jr
Year: 2018
Publication Place: United States
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
1032
Adolescents Who Do Not Endorse Risk via the Patient Health Questionnaire Before Self-Harm or Suicide
Type: Journal Article
Authors: J. P. Flores, G. Kahn, R. B. Penfold, E. A. Stuart, B. K. Ahmedani, A. Beck, J. M. Boggs, K. J. Coleman, Y. G. Daida, F. L. Lynch, J. E. Richards, R. C. Rossom, G. E. Simon, H. C. Wilcox
Year: 2024
Abstract:

IMPORTANCE: Given that the Patient Health Questionnaire (PHQ) item 9 is commonly used to screen for risk of self-harm and suicide, it is important that clinicians recognize circumstances when at-risk adolescents may go undetected. OBJECTIVE: To understand characteristics of adolescents with a history of depression who do not endorse the PHQ item 9 before a near-term intentional self-harm event or suicide. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective cohort study design using electronic health record and claims data from January 2009 through September 2017. Settings included primary care and mental health specialty clinics across 7 integrated US health care systems. Included in the study were adolescents aged 13 to 17 years with history of depression who completed the PHQ item 9 within 30 or 90 days before self-harm or suicide. Study data were analyzed September 2022 to April 2023. EXPOSURES: Demographic, diagnostic, treatment, and health care utilization characteristics. MAIN OUTCOME(S) AND MEASURE(S): Responded "not at all" (score = 0) to PHQ item 9 regarding thoughts of death or self-harm within 30 or 90 days before self-harm or suicide. RESULTS: The study included 691 adolescents (mean [SD] age, 15.3 [1.3] years; 541 female [78.3%]) in the 30-day cohort and 1024 adolescents (mean [SD] age, 15.3 [1.3] years; 791 female [77.2%]) in the 90-day cohort. A total of 197 of 691 adolescents (29%) and 330 of 1024 adolescents (32%), respectively, scored 0 before self-harm or suicide on the PHQ item 9 in the 30- and 90-day cohorts. Adolescents seen in primary care (odds ratio [OR], 1.5; 95% CI, 1.0-2.1; P = .03) and older adolescents (OR, 1.2; 95% CI, 1.0-1.3; P = .02) had increased odds of scoring 0 within 90 days of a self-harm event or suicide, and adolescents with a history of inpatient hospitalization and a mental health diagnosis had twice the odds (OR, 2.0; 95% CI, 1.3-3.0; P = .001) of scoring 0 within 30 days. Conversely, adolescents with diagnoses of eating disorders were significantly less likely to score 0 on item 9 (OR, 0.4; 95% CI, 0.2-0.8; P = .007) within 90 days. CONCLUSIONS AND RELEVANCE: Study results suggest that older age, history of an inpatient mental health encounter, or being screened in primary care were associated with at-risk adolescents being less likely to endorse having thoughts of death and self-harm on the PHQ item 9 before a self-harm event or suicide death. As use of the PHQ becomes more widespread in practice, additional research is needed for understanding reasons why many at-risk adolescents do not endorse thoughts of death and self-harm.

Topic(s):
Healthcare Disparities See topic collection
1033
Adopting national recommendations for clinical management of pediatric obesity in primary care
Type: Journal Article
Authors: N. Davila, J. Garcia, M. G. Reneau, W. Smith
Year: 2025
Abstract:

The World Health Organization reports that more than 390 million children and adolescents have obesity, with the US facing a prevalence of 14 million among this population and incurring an annual medical cost of $1.3 billion. Childhood and adolescent obesity stems from genetic, environmental, and socioecological factors, indicating the need for an evolving approach to pediatric obesity management. The updated 2023 American Academy of Pediatrics guideline for evaluation and treatment of pediatric obesity advocates for a child-centric strategy, considering health equity, racism, weight bias stigmatism, and adverse childhood experiences. Management includes intensive health behavior and lifestyle treatment, partnership with communities to build comprehensive treatment programs, promotion of early intervention, consideration of pharmacotherapy for children age 12 years and older, selective use of bariatric surgery, screening for and treatment of comorbidities, integration of mental health treatment, and use of motivational interviewing to engage patients in their care. Pediatric primary care providers play a key role in identification of obesity and encouragement of obesity treatment. Proactive management of childhood obesity benefits individuals, families, and the nation. Early intervention holds the promise of substantial cost savings on obesity-related healthcare. Healthcare providers wield significant influence in reducing childhood morbidity and enhancing the overall health of US children and adolescents.

Topic(s):
Healthcare Policy See topic collection
,
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
1035
Adoption of care management activities by primary care nurses for people with common mental disorders and physical conditions: A multiple case study
Type: Journal Article
Authors: Ariane Girard, Édith Ellefsen, Pasquale Roberge, Joëlle Bernard‐Hamel, Catherine Hudon
Year: 2021
Topic(s):
Education & Workforce See topic collection
1036
Adoption of Electronic Health Record Among Substance Use Disorder Treatment Programs: Nationwide Cross-Sectional Survey Study
Type: Journal Article
Authors: J. A. Frimpong, X. Liu, L. Liu, R. Zhang
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
HIT & Telehealth See topic collection
,
Financing & Sustainability See topic collection
,
Education & Workforce See topic collection
1037
Adoption of injectable naltrexone in U.S. substance use disorder treatment programs
Type: Journal Article
Authors: L. Aletraris, Bond Edmond, P. M. Roman
Year: 2015
Publication Place: United States
Abstract: OBJECTIVE: Medication-assisted treatment for substance use disorders (SUDs) is not widely used in treatment programs. The aims of the current study were to document the prevalence of adoption and implementation of extended-release injectable naltrexone, the newest U.S. Food and Drug Administration-approved medication for alcohol use disorder (AUD), in U.S. treatment programs and to examine associations between organizational and patient characteristics and adoption. METHOD: The study used interview data from a nationally representative sample of 307 U.S. SUD treatment programs to examine adoption and implementation of injectable naltrexone. RESULTS: Thirteen percent of programs used injectable naltrexone for AUD, and 3% of programs used it for opioid use disorder. Every treatment program that offered injectable naltrexone to its patients used it in conjunction with psychosocial treatment, particularly cognitive behavioral therapy. Multivariate logistic regression results indicated that adoption was positively associated with the provision of wraparound services, the percentage of privately insured patients, and the presence of inpatient detoxification services. For-profit status and offering inpatient services were negatively associated with adoption. Within adopting programs, an average of 4.1% of AUD patients and 7.1% of patients with opioid use disorder were currently receiving the medication, despite clinical directors' reports of positive patient outcomes, particularly for relapsers and for those who had been noncompliant with other medications. Cost was a significant issue for the majority of adopting organizations. CONCLUSIONS: The rate of adoption of injectable naltrexone in U.S. treatment programs remains limited. Researchers should continue to examine patient, organizational, and external characteristics associated with the adoption and implementation of injectable naltrexone over time.
Topic(s):
Opioids & Substance Use See topic collection
,
Financing & Sustainability See topic collection
1039
Adoption, penetration, and effectiveness of a secondary risk screener for intimate partner violence: Evidence to inform screening practices in integrated care settings
Type: Journal Article
Authors: K. M. Iverson, A. E. Sorrentino, S. L. Bellamy, A. R. Grillo, T. N. Haywood, E. Medvedeva, C. B. Roberts, M. E. Dichter
Year: 2018
Publication Place: United States
Abstract: OBJECTIVE: Veterans Health Administration (VHA) has implemented screening for past-year intimate partner violence (IPV) in some healthcare facilities along with secondary screening of risk for severe violence among those screening positive in order to facilitate follow-up care for high-risk patients. We evaluated the adoption, penetration, and effectiveness of secondary screening as a tool to facilitate timely follow-up services. METHODS: Retrospective review of medical records (screening and healthcare use) of 774 women screening positive for past-year IPV (IPV+) at 11 facilities nationwide from April 2014-April 2016. Chi-square and t-tests examined factors related to secondary screening. RESULTS: Three of eleven (27.3%) facilities that implemented primary IPV screening adopted secondary screening. At adopting sites, 56.4% eligible (i.e., IPV+) women received secondary screening. Among 185 IPV+ women who completed secondary screening, 33.0% screened positive for severe IPV. Screening positive during secondary screening was associated with higher rate of psychosocial care within 60days (73.8% vs. 54.0% of IPV+ patients screening negative; p50% vs. <15%; p<.001). CONCLUSIONS: Secondary risk assessment following IPV screening may expedite access to psychosocial follow-up care in integrated healthcare settings. However, program uptake needs to be enhanced.
Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection